BCRB 2018

Keratinocyte Growth Factor (Palifermin)

100

Grade 0

Grade 1

Grade 2

Grade 3

80

Grade 2

TBI + ChT Phase III randomised, placebo controlled

60

Grade 3

40

Grade 4

20

Incidence of mucositis [%]

Grade 4

0

Palifermin (rHuKGF) (n = 106) day -3, -2, -1 / 1, 2, 3

Placebo (n = 106)